CDK4 Restricts Triple-Negative Breast Cancer Cell Migration via Phosphorylation-Driven Activation of Myo9b RhoGAP Function
Kanishka Parashar, Laia Simó‐Riudalbas, Arianna Ravera, Silvia Prieto-Baños, David Moi, B. Drake, Jialin Shi, Sarah Geller, Christophe Dessimoz, Georg Ernest Fantner, Dorian V. Ziegler, Lluis Fajas A
This study shows CDK4 inhibits TNBC cell migration by phosphorylating Myo9b, which suppresses RhoA signaling, and suggests targeting Myo9b-RhoA could improve CDK4/6 inhibitor therapy.
bioRxiv · Aug 6, 2025 · PreprintCell Biology